55
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Effects of mono- and dialkylglucosides on the characterisation and blood circulation of lipid nanoemulsions

, , , &
Pages 738-746 | Received 22 Apr 2019, Accepted 20 Sep 2019, Published online: 16 Oct 2019

References

  • Al-Ali, A.A.A., et al., 2018. Nonionic surfactants increase digoxin in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure. International journal of pharmaceutics, 551(1–2), 270–280.
  • Argenta, D.F., et al., 2018. Topical delivery of coumestrol from lipid nanoemulsions thickened with hydroxyethylcellulose for antiherpes treatment. AAPS pharmscitech, 19(1), 192–200.
  • Awasthi, V.D., et al., 2003. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. International journal of pharmaceutics, 253(1–2), 121–132.
  • Camara, A.L.S., et al., 2017. Acid-sensitive lipidated doxorubicin prodrug entrapped in nanoemulsion impairs lung tumor metastasis in a breast cancer model. Nanomedicine, 12(15), 1751–1765.
  • Cao, X., et al., 2015. Coencapsulated doxorubicin and bromotetrandrine lipid nanoemulsions in reversing multidrug resistance in breast cancer in vitro and in vivo. Molecular pharmaceutics, 12(1), 274–286.
  • Cardoso, M.V.C., and Sabadini, E., 2013. Before and beyond the micellization of n-alkyl glycoside. A water-1H NMR relaxation study. Langmuir, 29(51), 15778–15786.
  • Chen, L., et al., 2017. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor. International journal of pharmaceutics, 534(1–2), 308–315.
  • Chonn, A., Semple, S.C., and Cullis, P.R., 1992. Association of blood proteins with large unilamellar liposomes in vivo. The journal of biological chemistry, 267(26), 18759–18765.
  • Dawes, W.H., and Groves, M.J., 1978. The effect of electrolytes on phospholipid-stabilized soyabean oil emulsions. International journal of pharmaceutics, 1(3), 141–150.
  • Desai, J., and Thakkar, H., 2019. Enhanced oral bioavailability and brain uptake of darunavir using lipid nanoemulsion formulation. Colloids and surfaces B: biointerfaces, 175, 143–149.
  • Fiorelli, A.I., et al., 2017. Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model. Brazilian journal of medical and biological research, 50(10), e6225/1–e6225/8.
  • Gbadamosi, J.K., Hunter, A.C., and Moghimi, S.M., 2002. PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance. Febs letters, 532(3), 338–344.
  • Kim, A., et al., 2017. Intravenous delivery of xenon incorporated in thermosensitive nano-emulsions for anesthesia. Journal of nanoscience and nanotechnology, 17(4), 2784–2790.
  • Kitamura, K., et al., 2007. 19F NMR spectroscopic characterization of the interaction of niflumic acid with human serum albumin. Analytical and bioanalytical chemistry, 387(8), 2843–2848.
  • Law, S.L., et al., 1988. The electrokinetic behavior of liposomes adsorbed with bovine serum albumin. International journal of pharmaceutics, 43(3), 257–260.
  • Law, S.L., et al., 1986. The adsorption of bovine serum albumin by liposomes. International journal of pharmaceutics, 32(2–3), 237–241.
  • Liu, Y., et al., 2017. Folate-functionalized lipid nanoemulsion to deliver chemo-radiotherapeutics together for the effective treatment of nasopharyngeal carcinoma. Aaps pharmscitech, 18(4), 1374–1381.
  • Madishetty, S., et al., 2015. Cationic diclofenac lipid nanoemulsion for improved oral bioavailability: preparation, characterization and in vivo evaluation. Journal of pharmaceutical sciences and nanotechnology, 8(2), 2874–2880.
  • Maeda, H., 1991. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Advanced drug delivery reviews, 6(2), 181–202.
  • Maeda, H., et al., 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. Journal of controlled release, 65(1-2), 271–284.
  • Matsumura, Y., and Maeda, H., 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer research, 46(12 Pt 1), 6387–6392.
  • Miyamoto, M., et al., 1999. Preparation of gadolinium-containing emulsions stabilized with phosphatidylcholine-surfactant mixtures for neutron-capture therapy. Chemical and pharmaceutical bulletin, 47(2), 203–208.
  • Natalini, C.C., et al., 2017. Intravenous 15% isoflurane lipid nanoemulsion for general anesthesia in dogs. Veterinary anaesthesia and analgesia, 44(2), 219–227.
  • Nielsen, S., et al., 2019. MRP2-medicated transport of etoposide in MDCKII MRP2 cells is unaffected by commonly used non-ionic surfactants. International journal of pharmaceutics, 565, 306–315.
  • Panagi, Z., et al., 1999. In vitro binding of HSA, IgG, and HDL on liposomes of different composition and its correlation with the BLOOD/RES ratio of liposomes. International journal of pharmaceutics, 176(2), 203–207.
  • Seki, J., et al., 1994. Lipid nano-sphere (LNS), a protein-free analogue of lipoproteins, as a novel drug carrier for parenteral administration. Journal of controlled release, 28(1–3), 352–353.
  • Tabata, Y., and Ikeda, Y., 1988. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials, 9(4), 356–362.
  • Takegami, S., et al., 2015. Application of 19F NMR spectroscopy using a novel α-tocopherol derivative as a 19F NMR probe for a pharmacokinetic study of lipid nano-emulsions in mice. Pharmaceutica analytica acta, 6(2), 339.
  • Takegami, S., et al., 2008. Preparation and characterization of a new lipid nano-emulsion containing two cosurfactants, sodium palmitate for droplet size reduction and sucrose palmitate for stability enhancement. Chemical & pharmaceutical bulletin, 56(8), 1097–1102.
  • Takegami, S., et al., 2010a. Distribution of chloroaluminum phthalocyanine in a lipid nano-emulsion as studied by second-derivative spectrophotometry. Micro and nanosystemse, 2(4), 280–285.
  • Takegami, S., et al., 2016. 19F nuclear magnetic resonance spectrometric determination of the partition coefficients of flutamide and nilutamide (antiprostate cancer drugs) in a lipid nano-emulsion and prediction of its encapsulation efficiency for the drugs. Aaps pharmscitech, 17(6), 1500–1506.
  • Takegami, S., et al., 2010b. Characterization, in vitro cytotoxicity and cellular accumulation of paclitaxel-loaded lipid nano-emulsions. Journal of microencapsulation, 27(5), 453–459.
  • Takegami, S., et al., 2012. Effect of bovine serum albumin on the stability of bicalutamide-encapsulated lipid nano-emulsion in bovine serum. Current nanoscience, 8(2), 187–192.
  • Takino, T., et al., 1993. Controlled biodistribution of highly lipophilic drugs with various parenteral formulations. Journal of drug targeting, 1(2), 117–124.
  • Takino, T., et al., 1994. Long circulating emulsion carrier systems for highly lipophilic drugs. Biological and pharmaceutical bulletin, 17(1), 121–125.
  • Wu, Y.B., and Lin, K.W., 2014. Influences of xylooligosaccharides and saccharides on the properties of meat batter during frozen storage. Journal of food processing and preservation, 38(4), 1439–1446.
  • Xu, F., et al., 2009. Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges. International journal of pharmaceutics, 377(1–2), 199–206.
  • Yamaoka, K., et al., 1981. A pharmacokinetic analysis program, (MULTI) for microcomputer. Journal of pharmacobio-dynamics, 4(11), 879–885.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.